These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 27322220

  • 1. Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes.
    Wei Y, Li M, Cui S, Wang D, Zhang CY, Zen K, Li L.
    Molecules; 2016 Jun 16; 21(6):. PubMed ID: 27322220
    [Abstract] [Full Text] [Related]

  • 2. miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2/cell cycle signaling axis.
    Xia X, Wang X, Zhang S, Zheng Y, Wang L, Xu Y, Hang B, Sun Y, Lei L, Bai Y, Hu J.
    J Cell Physiol; 2019 Aug 16; 234(10):18970-18984. PubMed ID: 30916359
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, Dana N, Javan M.
    Cell Oncol (Dordr); 2017 Oct 16; 40(5):457-470. PubMed ID: 28741069
    [Abstract] [Full Text] [Related]

  • 7. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
    Zhang J, Zhang HD, Yao YF, Zhong SL, Zhao JH, Tang JH.
    Cell Physiol Biochem; 2015 Oct 16; 36(6):2274-86. PubMed ID: 26279432
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells.
    Wen X, Li J, Cai D, Yue L, Wang Q, Zhou L, Fan L, Sun J, Wu Y.
    Molecules; 2018 Jan 29; 23(2):. PubMed ID: 29382149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition.
    Tabari AR, Gavidel P, Sabouni F, Gardaneh M.
    Mol Biol Rep; 2022 Jun 29; 49(6):4307-4319. PubMed ID: 35525887
    [Abstract] [Full Text] [Related]

  • 16. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.
    Gernapudi R, Yao Y, Zhang Y, Wolfson B, Roy S, Duru N, Eades G, Yang P, Zhou Q.
    Breast Cancer Res Treat; 2015 Apr 29; 150(3):685-95. PubMed ID: 25783182
    [Abstract] [Full Text] [Related]

  • 17. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
    Aslan C, Maralbashi S, Kahroba H, Asadi M, Soltani-Zangbar MS, Javadian M, Shanehbandi D, Baradaran B, Darabi M, Kazemi T.
    Life Sci; 2020 Oct 01; 258():118094. PubMed ID: 32673663
    [Abstract] [Full Text] [Related]

  • 18. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ.
    Mol Cancer; 2015 Jul 16; 14():133. PubMed ID: 26178901
    [Abstract] [Full Text] [Related]

  • 19. D Rhamnose β-Hederin against human breast cancer by reducing tumor-derived exosomes.
    Chen WX, Cheng L, Pan M, Qian Q, Zhu YL, Xu LY, Ding Q.
    Oncol Lett; 2018 Oct 16; 16(4):5172-5178. PubMed ID: 30250584
    [Abstract] [Full Text] [Related]

  • 20. Shikonin induces cell cycle arrest in human gastric cancer (AGS) by early growth response 1 (Egr1)-mediated p21 gene expression.
    Kim SJ, Kim JM, Shim SH, Chang HI.
    J Ethnopharmacol; 2014 Feb 12; 151(3):1064-1071. PubMed ID: 24384380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.